1K25
PBP2x from a Highly Penicillin-resistant Streptococcus pneumoniae Clinical Isolate
Summary for 1K25
Entry DOI | 10.2210/pdb1k25/pdb |
Related | 1QME 1QMF |
Descriptor | low-affinity PENICILLIN-BINDING PROTEIN 2X (2 entities in total) |
Functional Keywords | antibiotic resistance, clinical mutant, low-affinity penicillin-binding, membrane protein |
Biological source | Streptococcus pneumoniae |
Total number of polymer chains | 4 |
Total formula weight | 301037.72 |
Authors | Dessen, A.,Mouz, N.,Hopkins, J.,Dideberg, O. (deposition date: 2001-09-26, release date: 2001-10-31, Last modification date: 2024-02-07) |
Primary citation | Dessen, A.,Mouz, N.,Gordon, E.,Hopkins, J.,Dideberg, O. Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate: a mosaic framework containing 83 mutations. J.Biol.Chem., 276:45106-45112, 2001 Cited by PubMed Abstract: Penicillin-binding proteins (PBPs) are the main targets for beta-lactam antibiotics, such as penicillins and cephalosporins, in a wide range of bacterial species. In some Gram-positive strains, the surge of resistance to treatment with beta-lactams is primarily the result of the proliferation of mosaic PBP-encoding genes, which encode novel proteins by recombination. PBP2x is a primary resistance determinant in Streptococcus pneumoniae, and its modification is an essential step in the development of high level beta-lactam resistance. To understand such a resistance mechanism at an atomic level, we have solved the x-ray crystal structure of PBP2x from a highly penicillin-resistant clinical isolate of S. pneumoniae, Sp328, which harbors 83 mutations in the soluble region. In the proximity of the Sp328 PBP2x* active site, the Thr(338) --> Ala mutation weakens the local hydrogen bonding network, thus abrogating the stabilization of a crucial buried water molecule. In addition, the Ser(389) --> Leu and Asn(514) --> His mutations produce a destabilizing effect that generates an "open" active site. It has been suggested that peptidoglycan substrates for beta-lactam-resistant PBPs contain a large amount of abnormal, branched peptides, whereas sensitive strains tend to catalyze cross-linking of linear forms. Thus, in vivo, an "open" active site could facilitate the recognition of distinct, branched physiological substrates. PubMed: 11553637DOI: 10.1074/jbc.M107608200 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.2 Å) |
Structure validation
Download full validation report
